BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22115391)

  • 1. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 5. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
    Tursi A
    J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
    [No Abstract]   [Full Text] [Related]  

  • 6. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
    McDonnell MJ; Rutherford RM; O'Regan A
    J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions].
    Piqueras M; Monfort D; Pol MA; Galter S; Modolell I; Ortiz J; Boadas J
    Gastroenterol Hepatol; 2013; 36(6):396-9. PubMed ID: 23587662
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe psoriasis preceding diagnosis of large bowel Crohn's disease for 15 years.
    Triantafillidis JK; Malgarinos G
    J Crohns Colitis; 2013 Mar; 7(2):e80. PubMed ID: 22883442
    [No Abstract]   [Full Text] [Related]  

  • 9. Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab.
    Lipka S; Katz S; Ginzburg L
    J Crohns Colitis; 2013 Jun; 7(5):427-8. PubMed ID: 22926276
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
    J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of Adalimumab in Crohn's disease].
    Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic strategy for patients with Crohn's disease using of adalimumab].
    Motoya S; Yamashita M; Tanaka H
    Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):370-7. PubMed ID: 22398901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
    Lazebnik LB; Sagynbaeva VÉ
    Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease.
    Taxonera C; Mendoza JL; Ortega L; Pérez MI; Díaz-Rubio M
    J Crohns Colitis; 2012 May; 6(4):488-91. PubMed ID: 22398051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cost effectiveness of adalimumab in Crohn's disease (review of foreign pharmacoeconomic studies)].
    Rudakova AV
    Eksp Klin Gastroenterol; 2011; (9):113-9. PubMed ID: 22629787
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up.
    Hernández-Garfella ML; Gracia-García A; Cervera-Taulet E; García-Villanueva C; Montero-Hernández J
    J Crohns Colitis; 2011 Jun; 5(3):265-6. PubMed ID: 21575896
    [No Abstract]   [Full Text] [Related]  

  • 19. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
    Khosravi-Hafshejani T; Zhou Y; Dutz JP
    J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonals against TNF are a major advance in the treatment of Crohn's disease.
    Fraser A
    N Z Med J; 2014 Jun; 127(1396):10-4. PubMed ID: 24997459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.